Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Islet Transplantation Using Campath-1H and Infliximab Induction

This study has been completed.
Sponsor:
Collaborator:
Juvenile Diabetes Research Foundation
Information provided by:
University of Alberta
ClinicalTrials.gov Identifier:
NCT00175266
First received: September 12, 2005
Last updated: October 1, 2009
Last verified: October 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given
No publications provided by University of Alberta

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):